Reticulocalbin-1 activators consist of a diverse set of chemicals that predominantly center around the modulation of endoplasmic reticulum functions. These chemicals span a wide spectrum of actions, from inducing ER stress, altering calcium dynamics, to disrupting protein processing or degradation in the ER. Given RCN1's localization in the ER and its role in calcium binding, chemicals affecting these processes can play a role in its modulation. For instance, agents like Cyclopiazonic Acid, which affect the SERCA pump and subsequently deplete ER calcium, might impact RCN1 as the ER attempts to adapt to the altered calcium environment. Furthermore, chemicals like Tunicamycin and Brefeldin A, which interfere with protein processing and trafficking between the ER and Golgi, provide another angle of influence on RCN1. This is especially relevant given the ER's crucial role in ensuring proteins are correctly folded and post-translationally modified.
Other chemicals in this class, such as Dantrolene and 2-APB, pivot on the modulation of calcium release mechanisms from the ER. Given RCN1's calcium-binding role, any shift in ER calcium dynamics can position RCN1 in a pivotal spot for cellular adaptation. Another layer of modulation is brought in by MG-132, which, by affecting protein degradation routes, can lead to protein accumulation in the ER. The subsequent ER stress can trigger a cascade of events, including the unfolded protein response, where RCN1 might see modulated activity or expression. Together, these chemicals underscore the vast interconnectivity and importance of the ER in cellular function, and by extension, highlight the pathways and processes through which RCN1 can be influenced.
产品名称 | CAS # | 产品编号 | 数量 | 价格 | 应用 | 排名 |
---|---|---|---|---|---|---|
Dantrolene | 7261-97-4 | sc-500165 | 25 mg | $350.00 | 7 | |
丹曲林可调节雷诺丁受体,减少 ER 的钙释放。这可能会导致 ER 钙平衡发生变化,从而可能影响 RCN1 的功能。 | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $30.00 $52.00 $122.00 $367.00 | 25 | |
Brefeldin A 会破坏 ER-Golgi 的运输。这种干扰会导致ER中的蛋白质加工发生改变,并有可能在此过程中影响RCN1的活性。 | ||||||
2-APB | 524-95-8 | sc-201487 sc-201487A | 20 mg 100 mg | $27.00 $52.00 | 37 | |
2-APB 作用于 IP3 受体,改变 ER 的钙释放。这种作用会影响 ER 的钙平衡,从而可能调节 RCN1。 | ||||||
Nifedipine | 21829-25-4 | sc-3589 sc-3589A | 1 g 5 g | $58.00 $170.00 | 15 | |
硝苯地平是一种 L 型钙通道阻滞剂,可改变钙的动态变化。这可能会间接影响 ER 中 RCN1 的钙结合活性。 | ||||||
Cyclopiazonic Acid | 18172-33-3 | sc-201510 sc-201510A | 10 mg 50 mg | $173.00 $612.00 | 3 | |
它是 SERCA 泵的抑制剂,会消耗 ER 的钙储存。由此造成的ER钙失衡可能会影响RCN1的功能或水平。 | ||||||
Xestospongin C | 88903-69-9 | sc-201505 | 50 µg | $500.00 | 14 | |
作为一种 IP3 受体拮抗剂,Xestospongin C 会影响 ER 的钙释放,从而间接调节 RCN1 等钙结合蛋白。 | ||||||
Celastrol, Celastrus scandens | 34157-83-0 | sc-202534 | 10 mg | $155.00 | 6 | |
Celastrol通过影响蛋白质折叠诱导ER应激。由此产生的UPR可能会调节RCN1的表达或功能。 |